Overview

An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.

Status:
Completed

Trial end date:
2004-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate acetaminophen extended release (3900 mg/day) compared to placebo for safety and effectiveness in the relief of signs and symptoms of osteoarthritis of the hip or knee over 12 weeks

Phase:

Phase 3

Details

Lead Sponsor:

Johnson & Johnson Consumer and Personal Products Worldwide

Collaborator:

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Treatments:

Acetaminophen